Doctor profile · Federal record
Dr. Seth Permann, PA-C
Physician Assistant · Nampa, ID
- NPI 1508855974
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 21 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
318 2Nd St S
Nampa, ID 836513765
(208) 467-3006
fax (208) 467-1155
Credentials & registration
- NPI registered
- October 2005 — 21 yrs on file
- Profile last updated
- July 13, 2010
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Idaho #PA-567
- Medicaid
- ID #807287300
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1508855974. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,565
Distinct HCPCS
10
Medicare allowed
$125,922
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,624 | 291 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 589 | 462 | $70 | |
17000 |
Destruction of precancer skin growth, 1 growth | 429 | 359 | $42 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 213 | 29 | $1 | |
17110 |
Destruction of skin growth, 1-14 growths | 187 | 169 | $88 | |
11102 |
Biopsy of related skin growth, first growth | 94 | 84 | $71 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 80 | 80 | $87 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 68 | 53 | $100 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 66 | 65 | $44 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 64 | 55 | $131 |
In context: peer comparison
Among 22 peers in Nampa Physician Assistant, average services per provider: 90. This provider delivers 40× the peer median.Open Payments
Industry payments received
All-time total
$2,900
Transactions
79
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 12 | $1,450.24 | |
| Abbvie INC. | 25 | $668.96 | |
| Dermavant Sciences, INC. | 14 | $152.04 | |
| Regeneron Healthcare Solutions, INC. | 3 | $98.59 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 3 | $83.72 | |
| Sun Pharmaceutical Industries INC. | 3 | $82.25 | |
| Lilly USA, LLC | 3 | $67.67 | |
| Incyte Corporation | 3 | $59.89 | |
| Arcutis Biotherapeutics, INC. | 3 | $53.30 | |
| Galderma Laboratories, L.P. | 3 | $52.65 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $49.98 | |
| Ucb, INC. | 2 | $34.69 | |
| Leo Pharma INC. | 1 | $24.86 | |
| Novartis Pharmaceuticals Corporation | 1 | $21.19 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,162
Patients
630
Total drug cost
$31,555
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 212 | 102 | $3,301 |
| Clobetasol Propionate | Generic | 198 | 105 | $13,825 |
| Triamcinolone Acetonide | Generic | 155 | 113 | $1,342 |
| Hydrocortisone | Generic | 134 | 93 | $838 |
| Fluocinonide | Generic | 80 | 45 | $4,174 |
| Doxycycline Monohydrate | Generic | 68 | 17 | $2,165 |
| Minoxidil | Generic | 51 | 21 | $457 |
| Hydroxyzine Hcl | Generic | 47 | 21 | $681 |
| Cephalexin | Generic | 38 | 33 | $345 |
| Terbinafine Hcl | Generic | 38 | 27 | $216 |
Hospital affiliations
Frequently asked questions
What is Dr. Seth Permann's medical specialty?
Dr. Seth Permann practices Physician Assistant in Nampa, ID.
Where does Dr. Seth Permann practice?
Dr. Seth Permann practices at 318 2Nd St S, Nampa, ID 836513765. Office phone: 2084673006.
What is Dr. Seth Permann's NPI?
Dr. Seth Permann's National Provider Identifier (NPI) is 1508855974, issued by NPPES.
Does Dr. Seth Permann accept Medicare assignment?
Yes. Dr. Seth Permann accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Seth Permann commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.